These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19122337)

  • 1. Effect of clarithromycin on the pharmacokinetics of pranlukast in healthy volunteers.
    Nakade S; Yamauchi A; Komaba J; Ohno T; Kitagawa J; Honda N; Hasegawa C; Yoneda K; Kodama Y; Yasuda K; Azuma J; Miyata Y
    Drug Metab Pharmacokinet; 2008; 23(6):428-33. PubMed ID: 19122337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of sumatriptan when administered with clarithromycin in healthy volunteers.
    Moore KH; Leese PT; McNeal S; Gray P; O'Quinn S; Bye C; Sale M
    Clin Ther; 2002 Apr; 24(4):583-94. PubMed ID: 12017403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic interaction between amprenavir and clarithromycin in healthy male volunteers.
    Brophy DF; Israel DS; Pastor A; Gillotin C; Chittick GE; Symonds WT; Lou Y; Sadler BM; Polk RE
    Antimicrob Agents Chemother; 2000 Apr; 44(4):978-84. PubMed ID: 10722500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pranlukast, an oral leukotriene receptor antagonist, on leukotriene D4 (LTD4) challenge in normal volunteers.
    O'Shaughnessy TC; Georgiou P; Howland K; Dennis M; Compton CH; Barnes NC
    Thorax; 1997 Jun; 52(6):519-22. PubMed ID: 9227717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic drug interaction and safety after coadministration of clarithromycin, amoxicillin, and ilaprazole: a randomised, open-label, one-way crossover, two parallel sequences study.
    Jin BH; Yoo BW; Park J; Kim JH; Lee JY; Shin JS; Park MS
    Eur J Clin Pharmacol; 2018 Sep; 74(9):1149-1157. PubMed ID: 29846770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic evaluation of the interaction between etravirine and rifabutin or clarithromycin in HIV-negative, healthy volunteers: results from two Phase 1 studies.
    Kakuda TN; Woodfall B; De Marez T; Peeters M; Vandermeulen K; Aharchi F; Hoetelmans RM
    J Antimicrob Chemother; 2014 Mar; 69(3):728-34. PubMed ID: 24155058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of lansoprazole, amoxicillin and clarithromycin after simultaneous and single administration.
    Mainz D; Borner K; Koeppe P; Kotwas J; Lode H
    J Antimicrob Chemother; 2002 Nov; 50(5):699-706. PubMed ID: 12407126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The single and multiple dose pharmacokinetics of pranlukast in healthy volunteers.
    Brocks DR; Upward JW; Georgiou P; Stelman G; Doyle E; Allen E; Wyld P; Dennis MJ
    Eur J Clin Pharmacol; 1996; 51(3-4):303-8. PubMed ID: 9010703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro metabolism and inhibitory effects of pranlukast in human liver microsomes.
    Yoneda K; Matsumoto I; Sutoh F; Higashi R; Nunoya K; Nakade S; Miyata Y; Ogawa M
    Biol Pharm Bull; 2009 Apr; 32(4):688-93. PubMed ID: 19336906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics of pranlukast in healthy young and elderly subjects.
    Brocks DR; Upward J; Hust R; Köester FE; Collie H; Qian Y; Dennis MJ
    Int J Clin Pharmacol Ther; 1996 Sep; 34(9):375-9. PubMed ID: 8880285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open-label, randomized, single-center, two-period, phase I, crossover study of the effect of zibotentan (ZD4054) on the pharmacokinetics of midazolam in healthy male volunteers.
    Tomkinson HK; Kemp JV; Wollseifen T; Morris T; Oliver SD
    Clin Ther; 2010 Jul; 32(7):1372-86. PubMed ID: 20678684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pranlukast: a review of its use in the management of asthma.
    Keam SJ; Lyseng-Williamson KA; Goa KL
    Drugs; 2003; 63(10):991-1019. PubMed ID: 12699401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of pranlukast hydrate dry syrup in children with allergic rhinitis and bronchial asthma.
    Nakade S; Ueda S; Ohno T; Nakayama K; Miyata Y; Yukawa E; Higuchi S
    Drug Metab Pharmacokinet; 2006 Apr; 21(2):133-9. PubMed ID: 16702733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evening dosing is associated with higher plasma concentrations of pranlukast, a leukotriene receptor antagonist, in healthy male volunteers.
    Brocks DR; Upward J; Davy M; Howland K; Compton C; McHugh C; Dennis MJ
    Br J Clin Pharmacol; 1997 Sep; 44(3):289-91. PubMed ID: 9296325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and comparative bioavailability study of two clarithromycin suspensions following administration of a single oral dose to healthy volunteers.
    Zakeri-Milani P; Valizadeh H; Ghanbarzadeh S; Nemati M
    Arzneimittelforschung; 2009; 59(8):429-32. PubMed ID: 19813467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind non-inferiority clinical study of montelukast, a cysteinyl leukotriene receptor 1 antagonist, compared with pranlukast in patients with seasonal allergic rhinitis.
    Okubo K; Baba K
    Allergol Int; 2008 Dec; 57(4):383-90. PubMed ID: 18946234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic interaction between ritonavir and clarithromycin.
    Ouellet D; Hsu A; Granneman GR; Carlson G; Cavanaugh J; Guenther H; Leonard JM
    Clin Pharmacol Ther; 1998 Oct; 64(4):355-62. PubMed ID: 9797791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects.
    Hamilton A; Faiferman I; Stober P; Watson RM; O'Byrne PM
    J Allergy Clin Immunol; 1998 Aug; 102(2):177-83. PubMed ID: 9723658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of leukotriene receptor antagonist in bronchial hyperresponsiveness and hypersensitivity to analgesic in aspirin-intolerant asthma.
    Yoshida S; Sakamoto H; Ishizaki Y; Onuma K; Shoji T; Nakagawa H; Hasegawa H; Nakabayashi M; Amayasu H
    Clin Exp Allergy; 2000 Jan; 30(1):64-70. PubMed ID: 10606932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.